- Report
- April 2025
- 299 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- March 2025
- 140 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- November 2024
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- May 2023
- 180 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- January 2024
- 112 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 112 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- November 2021
- 545 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- March 2022
- 286 Pages
Global
From €3145EUR$3,456USD£2,696GBP
The Next Generation Sequencer (NGS) market is a subset of the biotechnology industry that focuses on the development and commercialization of sequencing technologies. NGS technology is used to rapidly sequence DNA and RNA molecules, allowing for the analysis of genetic information. This technology has enabled researchers to gain insights into the genetic basis of diseases, as well as to develop new treatments and diagnostics. NGS technology has also been used to study the evolution of species, to identify new species, and to develop new crop varieties.
The NGS market is highly competitive, with a number of companies offering sequencing technologies. These companies include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more
